1. Home
  2. TH vs NKTR Comparison

TH vs NKTR Comparison

Compare TH & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$18.71

Market Cap

1.8B

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$69.19

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TH
NKTR
Founded
1978
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.2B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
TH
NKTR
Price
$18.71
$69.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$16.50
$146.67
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
05-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$320,635,000.00
$307,711,000.00
Revenue This Year
$17.45
N/A
Revenue Next Year
$38.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
86.00
52 Week Low
$5.97
$21.02
52 Week High
$20.85
$109.00

Technical Indicators

Market Signals
Indicator
TH
NKTR
Relative Strength Index (RSI) 49.01 56.47
Support Level $15.95 $64.30
Resistance Level $18.83 $76.67
Average True Range (ATR) 0.83 3.45
MACD -0.11 1.34
Stochastic Oscillator 32.74 79.87

Price Performance

Historical Comparison
TH
NKTR

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services, including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. The company has three reportable segments: HFS - South, which provides specialty rental and hospitality services to the natural resources and development industry; WHS, which provides construction and hospitality solutions for critical mineral and data center projects; and Government, which provides specialty rental and hospitality services under government contracts.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: